---
id: "entity-mount-sinai-ai"
type: "entity"
entityType: "organization"
canonicalName: "Icahn School of Medicine at Mount Sinai AI Small Molecule Drug Discovery Center"
aliases: ["Mount Sinai AI Drug Discovery Center", "Icahn School of Medicine at Mount Sinai"]
source_timestamps: ["§ 2. Integrate emerging technologies into the drug-development process.", "¶12"]
tags: ["ai-research", "case-study"]
related: ["concept-self-driving-labs"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# Icahn School of Medicine at Mount Sinai — AI Small Molecule Drug Discovery Center

A recently launched center at the **Icahn School of Medicine at Mount Sinai** designed to integrate **generative AI approaches with traditional medicinal chemistry** to expedite the design and development of new drugs. It is a named example under Pillar 2 of the [[framework-amc-innovation-acceleration]] and illustrates the AI side of [[concept-self-driving-labs]].

**Enrichment context:** Mount Sinai's AI small-molecule efforts fit a broader trend of academic centers adopting AI-enabled discovery platforms.